News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
90 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Lexington Biosciences Announces Exercise of Warrants
As a result of the exercise of these warrants, the Corporation now has 37,853,401 common shares outstanding.
January 11, 2018
·
4 min read
Business
Endonovo Therapeutics Engages ShareIntel, A Leader in Shareholder Intelligence Services to Investigate Market Maker and Clearing Firm Irregularities
This will enable Endonovo to proactively track equity flows, identify parties to suspicious, aberrant and/or unusual trading activity and deploy action steps to help curtail such activity.
January 11, 2018
·
3 min read
Deals
Charles River Laboratories Acquires KWS BioTest
The addition of KWS enhances Charles River’s discovery expertise, with complementary offerings that provide our clients with additional tools in the active therapeutic research areas of oncology and immunology.
January 11, 2018
·
3 min read
Business
Forty Seven to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer
Forty Seven today announced an agreement with Merck KGaA, Darmstadt, Germany to conduct a Phase 1b clinical trial combining Hu5F9-G4 with avelumab* in patients with ovarian cancer.
January 11, 2018
·
5 min read
Deals
LENSAR Acquires Laser Business Assets of Precision Eye Services
Financial terms of the acquisition were not disclosed.
January 11, 2018
·
3 min read
Bio NC
DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym Version 7A
DILIsym Services Inc. announced that it has released Version 7A of its flagship QSP (quantitative systems pharmacology) modeling program, DILIsym.
January 11, 2018
·
5 min read
Drug Development
Cour Pharma Receives FDA Fast Track Designation for Timp-Glia
By encapsulating a component of wheat within a nanoparticle, Cour is developing a novel treatment which resulted in gluten tolerance in numerous animal models.
January 11, 2018
·
3 min read
Business
PREMIER Biosoft Announces a Research Collaboration With The Biomolecular Sciences Institute at Florida International University to Advance Lipidomics Research.
Under the collaboration, PREMIER Biosoft and Dr. Francisco Fernandez-Lima, from the Biomolecular Sciences Institute at Florida International University will work closely to power research in small as well as large molecule identification and quantification.
January 11, 2018
·
2 min read
STEMCELL Technologies Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community
STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab.
January 11, 2018
·
4 min read
BioMidwest
Open Therapeutics Integrates Overleaf Manuscript Development Platform Into Therapoid
Open Therapeutics announces the planned integration of Overleaf into its novel scientific collaboration platform, Therapoid.
January 11, 2018
·
2 min read
Previous
9 of 9